UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors

    • Categories

    Archives

    Apr

    22

    Earth Day 2025: Advancing Our Commitment to a Healthier Planet

    Read More Share:linkedin| twitter| email

    Apr

    03

    UCB presents latest research across leading neurology portfolio at American Academy of Neurology (AAN) meeting 2025

    Read More Share:linkedin| twitter| email

    Mar

    31

    The First UCB US Rare Disease Connect in Neurology (RDCN) Annual Summit Launches at American Academy of Neurology 2025

    Read More Share:linkedin| twitter| email

    Mar

    28

    Join UCB at the MGFA National Patient Conference and Visit Our Experience Room

    Read More Share:linkedin| twitter| email

    Mar

    27

    UCB’s Kassandra Watson and Windy Wang Recognized by Healthcare Businesswomen’s Association (HBA) as Luminary and Rising Star

    Read More Share:linkedin| twitter| email

    Mar

    19

    New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference

    Read More Share:linkedin| twitter| email

    Mar

    12

    Epilepsia Publishes Final Analysis of Open-Label Extension Study of Long-Term Safety and Effectiveness of FINTEPLA® (fenfluramine) in Children and Adults with Dravet Syndrome

    Read More Share:linkedin| twitter| email

    Mar

    07

    Improving Dermatology Outcomes with Timely Diagnosis and Long-Lasting Treatment Options

    Read More Share:linkedin| twitter| email

    Mar

    07

    BIMZELX® (bimekizumab-bkzx) Two-Year Data at AAD Showed Potential to Eliminate Draining Tunnels in Hidradenitis Suppurativa, and Reduction in Disease Burden

    Read More Share:linkedin| twitter| email

    Mar

    07

    BIMZELX® (bimekizumab-bkzx) Five-Year Data at AAD 2025 Showed Sustained Skin Clearance and Long-Term Efficacy in Moderate-to-Severe Plaque Psoriasis

    Read More Share:linkedin| twitter| email

    © 2009 - 2020 UCB, Inc., Atlanta. All rights reserved.
    USPR-CORP-0115-00003(2)